Tisler, Anna
Uusküla, Anneli
Ojavee, Sven Erik
Läll, Kristi
Metspalu, Andres
Milani, Lili
Esko, Tõnu
Mägi, Reedik
Nelis, Mari
Hudjashov, Georgi
Laisk, Triin
,
Funding for this research was provided by:
EEA Grants/Norway Grants (EMP416)
Eesti Teadusagentuur (PSG776, PRG1911, PSG776, PRG1911, PSG776, PRG1911)
European Regional Development Fund Project (2014-2020.4.01.15-0012 GENTRANSMED, 2014-2020.4.01.15-0012 GENTRANSMED, 2014-2020.4.01.15-0012 GENTRANSMED)
Article History
Received: 20 June 2023
Accepted: 29 November 2023
First Online: 7 December 2023
Declarations
:
: The study was carried out under ethical approval 1.1-12/624 from the Estonian Committee on Bioethics and Human Research (Estonian Ministry of Social Affairs) and data release N05 from the EstBB. The study has been conducted according to the Declaration of Helsinki. All participants provided written informed consent to participate in the Estonian Biobank. The UK Biobank study was approved by the North West Multi-Centre Research Ethics Committee (reference for UK Biobank is 16/NW/0274). All participants provided written informed consent to participate in the UK Biobank study. The cross-sectional survey was approved by the Research Ethics Committee of the University of Tartu (protocols 300/T-17 20.01.2020, 332/M-7 21.12.2020) and by the Estonian Committee on Bioethics and Human Research (protocol 1.1-12/660) 14.01.2021.
: The authors declare that they have no competing interests.